Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2018 | 04-2018 | 01-2018 | 10-2017 | 07-2017 | |
| Sales | 1,131 | 1,747 | 2,056 | 0 | 3,052 |
| Gross Profit | 1,131 | 1,747 | 2,056 | N/A | 3,052 |
| Operating Expenses | 15,295 | 15,300 | 22,603 | 0 | 35,789 |
| Operating Income | -14,164 | -13,553 | -20,547 | N/A | -32,737 |
| Other Income | 147 | 145 | 105 | 0 | 112 |
| Pre-tax Income | -14,017 | -13,408 | -20,442 | 0 | -32,625 |
| Income Tax | N/A | N/A | 50 | N/A | N/A |
| Net Income Continuous | -14,017 | -13,408 | -20,492 | N/A | -32,625 |
| Net Income | $-14,017 | $-13,408 | $-20,492 | $N/A | $-32,625 |
| EPS Basic Total Ops | -319.20 | -322.40 | -587.71 | N/A | -959.52 |
| EPS Basic Continuous Ops | -319.38 | -322.70 | -593.27 | N/A | -963.57 |
| EPS Diluted Total Ops | -319.20 | -322.40 | -587.71 | N/A | -959.52 |
| EPS Diluted Continuous Ops | -319.38 | -322.70 | -593.27 | N/A | -963.57 |
| EBITDA(a) | $-13,784 | $-13,185 | $-20,186 | $N/A | $-32,383 |